K-numberK251836
Device nameDermatrix Duo
ApplicantShenzhen Gsd Technology Co., Ltd.
Product codeGEI
Device classClass II
Decision dateFeb 6, 2026
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Dermatrix Duo is a radiofrequency system for dermatologic procedures with two handpieces: a Microneedle RF (MFR) handpiece with 16 or 49 needle cartridges for microneedling, and a Superficial RF (SFR) handpiece with 64 non-invasive electrodes. The device is intended for electrocoagulation and hemostasis, and the SFR applicator is indicated for relief of minor muscle aches, pain, muscle spasm, and temporary improvement of local blood circulation.

Technological characteristics

The subject device operates at 1 MHz bipolar frequency with maximum power of 50W, compared to predicates that support 1–2 MHz and higher power. The microneedle diameter is 0.2 mm (smaller than predicate's 0.3 mm); needle configurations differ (16 and 49 needles vs. predicate's 36 and 1). The SFR applicator has an electrode area of 441 mm² and RF duration of 10–400 ms, whereas the predicate offers up to 614.7 mm² and up to 30 seconds duration.

Test standards cited

IEC 60601-1 Edition 3.2, IEC 60601-1-2:2014, IEC TS 60601-4-2 Edition 1.0, IEC 60601-2-2:2017, ISO 10993-1, IEC 62304:2006+A1:2015, and EN ISO 14971:2012. Biocompatibility testing included cytotoxicity, sensitization, irritation, systemic toxicity, and pyrogen testing. Ex-vivo histology testing and tissue heating testing were performed per FDA guidance.

Substantial equivalence argument

The Dermatrix Duo is substantially equivalent because it has the same indications for use, technology (radiofrequency), mechanism of action (thermal coagulation), and operational principles as the Virtue RF and EndyMed MiniShaper Max predicates. Although there are differences in frequency, power, needle configuration, and electrode area, performance testing (histology and tissue heating) demonstrated that the subject device creates similar thermal damage patterns and maintains therapeutic temperatures equivalent to the predicates, establishing that these differences do not raise different safety or effectiveness questions.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →